1-10 of 10
Authors: Lorena de la Mora
Journal Article
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study Get access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 9, September 2024, Pages 2343–2353, https://doi.org/10.1093/jac/dkae235
Published: 24 July 2024
Journal Article
Effectiveness, safety and discontinuation rates of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV using real-world data: a systematic review and meta-analysis Get access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 8, August 2024, Pages 1775–1783, https://doi.org/10.1093/jac/dkae138
Published: 17 May 2024
Journal Article
Efficacy and safety of raltegravir plus lamivudine maintenance therapy Free
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 2, February 2024, Pages 255–261, https://doi.org/10.1093/jac/dkad364
Published: 01 December 2023
Journal Article
Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life setting Free
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 12, December 2023, Pages 2961–2967, https://doi.org/10.1093/jac/dkad338
Published: 24 October 2023
Journal Article
Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study Free
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 8, August 2023, Pages 1955–1962, https://doi.org/10.1093/jac/dkad189
Published: 13 June 2023
Journal Article
Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study Free
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 7, July 2022, Pages 1974–1979, https://doi.org/10.1093/jac/dkac137
Published: 05 May 2022
Journal Article
Integrase resistance emergence with dolutegravir/lamivudine with prior HIV-1 suppression Free
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 6, June 2022, Pages 1738–1740, https://doi.org/10.1093/jac/dkac082
Published: 11 March 2022
Journal Article
Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre Free
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 4, April 2022, Pages 1133–1139, https://doi.org/10.1093/jac/dkab481
Published: 19 January 2022
Journal Article
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19 Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 12, December 2021, Pages 3296–3302, https://doi.org/10.1093/jac/dkab321
Published: 02 September 2021
Journal Article
Factors associated with the use and composition of two-drug regimens in a large single-centre HIV cohort Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 11, November 2021, Pages 2988–2992, https://doi.org/10.1093/jac/dkab261
Published: 22 July 2021
